Lantheus Holdings (LNTH) Leases (2019 - 2025)
Lantheus Holdings' (LNTH) quarterly Leases came in at $31.0 million in Q4 2025, down 14.16% year-on-year from $36.1 million in Q4 2024, and down 14.16% on a QoQ basis from $36.1 million in Q4 2024.
Lantheus Holdings (LNTH) Leases (2019 - 2025) Analysis & Trends
Lantheus Holdings (LNTH) has 7 years of Leases data on file, last reported at $31.0 million in Q4 2025.
- On a quarterly basis, Leases fell 14.16% year-over-year to $31.0 million in Q4 2025; TTM through Dec 2025 was $31.0 million, a 14.16% decrease from a year earlier, with the FY2025 full-year figure at $31.0 million, down 14.16% from the prior year.
- Leases for Q4 2025 stood at $31.0 million, down from $36.1 million in the prior quarter.
- Over the last five years, Leases for LNTH reached as high as $45.3 million in Q4 2023 and fell as low as $400000.0 in Q2 2023.
- Historically, Leases has averaged $11.6 million across 5 years, with a median of $1.4 million in 2024.
- On a YoY basis, Leases climbed as much as 2982.72% in 2023 and fell as far as 95.29% in 2023.
- Year by year, Leases stood at $8.8 million in 2021, then jumped by 116.58% to $19.0 million in 2022, then jumped by 138.14% to $45.3 million in 2023, then retreated by 20.39% to $36.1 million in 2024, then dropped by 14.16% to $31.0 million in 2025.
- Per Business Quant data, the three most recent Leases figures were $31.0 million in Q4 2025, $36.1 million in Q4 2024, and $1.2 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 335.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 282.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 1.06 Mn |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 253.00 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 447.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Lantheus Holdings | 7.04 Bn | 6.54 Bn | 230.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.98 Mn |
| Dec 31, 2024 | 36.08 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.43 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 45.33 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Jun 30, 2023 | 400,000.00 |
| Mar 31, 2023 | 18.56 Mn |
| Dec 31, 2022 | 19.03 Mn |
| Sep 30, 2022 | 679,000.00 |
| Jun 30, 2022 | 8.48 Mn |
| Mar 31, 2022 | 602,000.00 |
| Dec 31, 2021 | 8.79 Mn |
| Sep 30, 2021 | 508,000.00 |
| Dec 31, 2020 | 18.44 Mn |
| Dec 31, 2019 | 348,000.00 |
| Sep 30, 2019 | 979,000.00 |
| Jun 30, 2019 | 1.02 Mn |
| Mar 31, 2019 | 1.06 Mn |